Page last updated: 2024-11-05
2,3,4-trimethylpentane
Description
2,3,4-trimethylpentane : An alkane that is pentane substituted by a methyl group at positions 2,3 and 4. It is a constituent of gasoline. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]
Cross-References
| ID Source | ID |
|---|
| PubMed CID | 11269 |
| CHEBI ID | 165735 |
| MeSH ID | M0150375 |
Synonyms (26)
| Synonym |
|---|
| woj1qvr6oa , |
| unii-woj1qvr6oa |
| 4-01-00-00446 (beilstein handbook reference) |
| AKOS015841803 |
| 2,3,4-trimethylpentane |
| pentane, 2,3,4-trimethyl- |
| nsc24846 |
| 565-75-3 |
| nsc-24846 |
| pentane,3,4-trimethyl- |
| brn 1696869 |
| einecs 209-292-6 |
| nsc 24846 |
| 2,3,4-trimethylpentane, 98% |
| CHEBI:165735 |
| 2,3,4-trimethyl-pentane |
| T0482 |
| LMFA11000711 |
| FT-0609400 |
| 1,1-diisopropylethane |
| DTXSID6060343 |
| RLPGDEORIPLBNF-UHFFFAOYSA-N |
| (ch3)2chch(ch3)ch(ch3)2 |
| mfcd00008924 |
| Q2813774 |
| T72628 |
Research Excerpts
Dosage Studied
| Excerpt | Relevance | Reference |
|---|
| " Of the C8-isomers, 2,3,4-trimethylpentane dosing leads to the highest incidence of kidney damage in male rats." | ( Identification of urinary metabolites in rats exposed to the nephrotoxic agent 2,3,4-trimethylpentane.
Hobson, DW; Olson, CT; Serve, MP; Yu, KO, 1987) | 0.82 |
Roles (2)
| Role | Description |
|---|
| mammalian metabolite | Any animal metabolite produced during a metabolic reaction in mammals. |
| nephrotoxic agent | A role played by a chemical compound exihibiting itself through the ability to induce damage to the kidney in animals. |
| [role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res] |
Drug Classes (2)
| Class | Description |
|---|
| alkane | An acyclic branched or unbranched hydrocarbon having the general formula CnH2n+2, and therefore consisting entirely of hydrogen atoms and saturated carbon atoms. |
| volatile organic compound | Any organic compound having an initial boiling point less than or equal to 250 degreeC (482 degreeF) measured at a standard atmospheric pressure of 101.3 kPa. |
| [compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res] |
Research
Studies (7)
| Timeframe | Studies, This Drug (%) | All Drugs % |
|---|
| pre-1990 | 5 (71.43) | 18.7374 |
| 1990's | 1 (14.29) | 18.2507 |
| 2000's | 1 (14.29) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |
Market Indicators
Research Demand Index: 47.04
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be strong demand-to-supply ratio for research on this compound.
| Metric | This Compound (vs All) |
|---|
| Research Demand Index | 47.04 (24.57) | | Research Supply Index | 2.08 (2.92) | | Research Growth Index | 4.18 (4.65) | | Search Engine Demand Index | 67.83 (26.88) | | Search Engine Supply Index | 2.00 (0.95) |
| |
Study Types
| Publication Type | This drug (%) | All Drugs (%) |
|---|
| Trials | 0 (0.00%) | 5.53% |
| Reviews | 0 (0.00%) | 6.00% |
| Case Studies | 0 (0.00%) | 4.05% |
| Observational | 0 (0.00%) | 0.25% |
| Other | 7 (100.00%) | 84.16% |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |